Merch Store

COVID-19 UPDATE: NYC serological study suggest 13X > prevalence = 1.7mm asymptomatic NYC-ers (of 8.4mm residents). Changes calculus: Treatment > Testing > Vaccine

COVID-19 remains a global crisis and we realize that many people need to keep up with COVID-19 developments, particularly since we are moving into the more critical stage ("restart economy"), so feel free to share our commentary to anyone who has interest.


Several states today and yesterday reported somewhat meaningful increases in COVID-19 cases, including NY, NJ, and MA.  But none of the governors, during their press briefings, seemed particularly concerned about this rise.  In total, US daily cases jumped to 32,179 (+3,269, a pretty sizable jump) with 75% of that attributable to NY, NJ, MA.  NY Gov Cuomo spent much of the time discussing the results of NY state serological study which found the prevalence of COVID-19 (based on antibodies) to be ~10X higher than previously thought and NYC with an estimated 21% of residents have been previously exposed (13X).  Cases are rising but state leaders are not sounding incrementally alarmed and perhaps this is a sign that hospitalizations, intubations, and death are their new benchmarks.

But what we think is the most meaningful development today is that NY state study is now the 5th serological study that shows vastly higher COVID-19 prevalence.  Why does this matter?  We think it casts the pandemic in a very different light, with COVID-19 likely asymptomatic for 92%-98% of those infected and 2% requiring hospitalizations.  If this is in fact correct, this means testing is far less important than treatment, and vaccines may be the least important.  And with such high prevalence, the convalescent plasma may be the most promising, since the data suggests there are as many as 46 donors of plasma in NYC for every patient that is hospitalized. Way more availability of plasma.

As for markets, stocks managed a flat day on a mixed earnings picture, plus terrible economic data as 4.4 million jobless claims show the economic damage is broadening.  But most investors are already aware that the economy is worsening.  In fact, the bigger element of uncertainty at the moment is the pace at which the consumer will re-engage, particularly with the "social distance taboo" of restaurants, travel, and entertainment. 

FYI, we quantify the consumer expenditures on these categories (see below) and it is ~$700 billion of the $8T consumer wallet and $14T of consumer PCE.  The largest share of consumer wallet is housing + transportation + food = 66% (mostly at home food).  So the social distance taboo is a relatively large 9% but if the US follows the path of China and these categories worth $700 billion see a 33% overall lower level (vs pre-pandemic), this represents a 3% overall hit to consumer expenditures. 

In other words, once the economy is re-started, the "hole" that will need to be filled by that potential 33% drop is $240 billion, which is not a deep a hole as one imagined a month ago.



POINT #1: NYC serological study (early) points to 13X > prevalence compared to "confirmed" cases
One of the more notable developments today was NY Gov. Cuomo announcing the results of a serological study (antibody-based) of NY state.  According to the NY study, 3,000 residents of the state were randomly tested (subjects found at grocery stores + shopping locations in 19 counties).  We did not have access to the full report and are presenting the data as disclosed in his press briefing.

-  The most surprising statistic is that Cuomo suggested at ~14% of NY state residents have already been exposed to COVID-19, which is 10X the "official" case count.

-  For NYC, the estimate is >21% of NYC has COVID-19 antibodies and is 13X the official estimate.

-  This is now the 5th fairly large scale serological study and the summary of the other 4 are shown below: Los Angeles County, Chelsea, MA, San Francisco, and Gengelt, Germany. 

As we noted in an earlier FLASH, the conclusions for these studies is largely the same.  The actual prevalence of COVID-19, based on antibodies is 13X to 50X to 80X greater than official tallies.

COVID-19 UPDATE: NYC serological study suggest 13X > prevalence = 1.7mm asymptomatic NYC-ers (of 8.4mm residents). Changes calculus: Treatment > Testing > Vaccine
Source: Fundstrat and various academic studies.
You are trying to access FSI member-only content.
You need to have an active FSI Macro, or FSI Pro subcription in order to read this article.
If you are already a member at FS Insight, please If you don’t have a subscription to FS Insight yet, you can sign up below.

We accept crypto via BitPay for yearly subscriptions.

Choose one of our yearly plans to save nearly 15%

    • Macro + Crypto
      FSI Pro
      The Complete Package
      FSI Macro + FSI Digital Assets
      from
      $
      249
      /mo
      billed anually
      First Month Free!
    • Macro
      FSI Macro
      from
      $
      199
      /mo
      billed anually
      First Month Free!
      What's included?
      Webinars and Media
      Webinars
      We host over 12 LIVE webinars per year with our research team and high-profile special guests. Incredible value and market insights!
      Weekly
      Coming Soon
      Fireside Chats
      Weekly interviews with our research heads about market opportunities and important updates.
      Research
      Weekdays
      Tom Lee's First Word
      The best market research out there -- on a near-daily basis.
      On market events
      Tom Lee's Intraday Word
      These are released periodically after crucial market developments.
      Daily
      Daily Technical Strategy
      Daily commentary on market trends and short term opportunities.
      Weekly
      Wall Street Whispers
      Exclusive insights based on discussions with institutional clients.
      Weekly
      Quantitative Strategy
      Quantitative market research utilizing industry-leading analytical methods.
      Weekly
      US Policy
      Weekly update on developments in Washington DC and how they may impact Wall Street.
      Weekly
      Weekly Roadmap
      Weekly summary of market events and updates on our key theses.
      Earnings season
      Earnings Daily
      A multi-faceted update of earnings developments.
      Updated bi-weekly
      Signal From Noise
      Highlights timely market themes and sectors with corresponding stocks, cutting through the day-to-day market “noise” for a distinct perspective.
      Stock Lists
      Updated quarterly
      Granny Shots
      Thematic investment stock picks that aim to outperform the S&P 500.
      Updated monthly
      Brian’s Dunks
      Single stock pics that are poised to outperform the index by leveraging sector outperformance and earning revisions strategies.
      Updated monthly
      FSI Sector Allocation
      A sector allocation strategy that is designed to outperform the S&P 500 while taking minimal risk.
      Updated monthly
      Factor Strategy
      List of ETFs based on quantitative models that should outperform the S&P 500 on a monthly basis.
      And More!
      FSI Academy
      Our main goal is to make you a better investor! This series will guide you through key financial concepts and topics in an understandable way.
      Community Questions
      We gather your inquiries and answer them in the most scalable way. Hear directly from our research principals!
      Community Interviews
      Get questions answered directly by our research heads and guest speakers.
      Get access to all the macro research on FS Insight
      First Month Free!
    • Crypto
      FSI Digital Assets
      from
      $
      99
      /mo
      billed anually
      First Month Free!
      What's included?
      Webinars and Media
      Webinars
      Ongoing webinars exploring crypto opportunities, in depth research, and exclusive research offerings from our team of analysts and leading cryptocurrency firms.
      Weekly
      Crypto Chats
      Digestible videos expanding on important market events and metrics that are shaping cryptocurrency markets.
      Research
      Daily
      Crypto Daily Report
      Stay on top of the crypto markets with macro commentary, technical analysis, and the most relevant news.
      Intra month
      Crypto First Word from Tom Lee
      Hear directly from Tom Lee about important cryptocurrency developments.
      Weekly
      Crypto Technical Strategy
      From Bitcoin, Ethereum and Solana to other coins, our Head of Technical Strategy highlights important price movement to help give you an edge.
      Weekly
      Crypto Weekly
      A must-read summarizing our key thoughts about the crypto market, price action, and developing trends.
      Weekly
      Funding Fridays
      Are you looking for investment opportunities in the crypto space? We explore early-stage crypto opportunities in this note about where the smart money is being invested!
      Weekly
      Coming Soon
      Crypto Events
      Never miss another conference, a high-impact software update, or an event that could be market-moving!
      Intra-month
      Deep Research Reports
      Our consulting business delivers incredible deep research reports to highlight the economics and viability of exciting crypto projects.
      Update daily
      Bitcoin Misery Index
      Keep track of bitcoin sentiment to plan your digital assets strategy.
      And More!
      FSI Academy
      Our main goal is to make you a better investor! This series will guide you through key financial concepts and topics in an understandable way.
      Community Questions
      We gather your inquiries and answer them in the most scalable way. Hear directly from our research principals!
      Community Interviews
      Get questions answered directly by our research heads and guest speakers.
      Get access to all the crypto research on FS Insight
      First Month Free!

More from the author

Disclosures (show)

Want to receive Regular Market Updates to your Inbox?

I am your default error :)